Arena Pharmaceuticals, Inc. Income (Loss) from Continuing Operations, Per Basic and Diluted Share
Arena Pharmaceuticals, Inc. reported Income (Loss) from Continuing Operations, Per Basic and Diluted Share of $1.35 per share for the 3-month period ending 2018-12-31, per its 10-K filed 2020-02-27.
Discontinued › Income Statement › Other Income
us-gaap:IncomeLossFromContinuingOperationsPerBasicAndDilutedShare · last filed 2020-02-27
- Arena Pharmaceuticals, Inc. income (loss) from continuing operations, per basic and diluted share for the quarter ending 2018-12-31 was $1.35.
- Arena Pharmaceuticals, Inc. income (loss) from continuing operations, per basic and diluted share for the quarter ending 2018-09-30 was -$0.70.
- Arena Pharmaceuticals, Inc. income (loss) from continuing operations, per basic and diluted share for the quarter ending 2018-06-30 was -$0.65.
- Arena Pharmaceuticals, Inc. income (loss) from continuing operations, per basic and diluted share for the quarter ending 2018-03-31 was -$0.78.
- Arena Pharmaceuticals, Inc. income (loss) from continuing operations, per basic and diluted share for fiscal 2018 was -$0.61.
- Arena Pharmaceuticals, Inc. income (loss) from continuing operations, per basic and diluted share for fiscal 2017 was -$2.87.
- Arena Pharmaceuticals, Inc. income (loss) from continuing operations, per basic and diluted share for fiscal 2016 was -$0.49.
- Arena Pharmaceuticals, Inc. income (loss) from continuing operations, per basic and diluted share for fiscal 2015 was -$4.60.
| Period end | Income (Loss) from Continuing Operations, Per Basic and Diluted Share 3 month | Income (Loss) from Continuing Operations, Per Basic and Diluted Share 6 month | Income (Loss) from Continuing Operations, Per Basic and Diluted Share 9 month | Income (Loss) from Continuing Operations, Per Basic and Diluted Share 12 month |
|---|---|---|---|---|
| 2018-12-31 | $1.35 10-K · filed 2020-02-27 | -$0.61 10-K · filed 2019-02-28 | ||
| 2018-09-30 | -$0.70 10-K · filed 2020-02-27 | -$2.10 10-Q · filed 2018-11-08 | ||
| 2018-06-30 | -$0.65 10-K · filed 2020-02-27 | -$1.41 10-Q · filed 2018-08-07 | ||
| 2018-03-31 | -$0.78 10-K · filed 2020-02-27 | |||
| 2017-12-31 | -$0.36 10-K · filed 2019-02-28 | -$2.87 10-K · filed 2019-02-28 | ||
| 2017-09-30 | -$0.93 10-K · filed 2019-02-28 | -$2.32 10-Q · filed 2018-11-08 | ||
| 2017-06-30 | -$0.77 10-K · filed 2019-02-28 | -$1.66 10-Q · filed 2018-08-07 | ||
| 2017-03-31 | -$0.90 10-K · filed 2019-02-28 | |||
| 2016-12-31 | -$0.49 10-K · filed 2019-02-28 | |||
| 2015-12-31 | -$4.60 10-K · filed 2018-03-14 |